+ All Categories
Home > Documents > ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016...

ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016...

Date post: 12-Jul-2016
Category:
Upload: shyam-sunder
View: 214 times
Download: 1 times
Share this document with a friend
5
Scanned by CamScanner
Transcript
Page 1: ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially

Scanned by CamScanner

Page 2: ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially

Scanned by CamScanner

Page 3: ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially

Scanned by CamScanner

Page 4: ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially

Scanned by CamScanner

Page 5: ZEMBRACEâ„¢ SymTouchâ„¢ (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially

Scanned by CamScanner


Recommended